Education
About Us
Working with TipRanks
Follow Us
Tandem Diabetes Care (TNDM)
:TNDM
Earnings Data
Report Date
Apr 30, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.6Last Year’s EPS
-0.65Same Quarter Last Year
Moderate Buy
Based on 15 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 26, 2025
|% Change Since: -41.02%
|Next Earnings Date:Apr 30, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted significant achievements, including record sales, the launch of the Control-IQ+ system, and expansion into the type 2 diabetes market. However, challenges remain with U.S. sales shortfalls, potential disruptions from sales force realignment, and international transition complexities. Overall, the positive developments and strategic initiatives indicate strong growth potential, though execution risks exist.Company Guidance
During the Tandem Diabetes Fourth Quarter and Year-End 2024 Earnings Conference Call, the company provided detailed guidance for 2025, highlighting key growth metrics and strategic initiatives. Tandem reported a record 2024 sales of $910 million, reflecting an 18% increase year-over-year, driven by strong pump shipments and operational efficiencies. The company anticipates worldwide sales in 2025 to range from $997 million to slightly over $1 billion, representing a 10% to 11% growth. In particular, U.S. sales are expected to grow 13% to 14%, supported by a strategic sales force expansion and enhanced market access through the Pharmacy channel, which now covers approximately 20% of U.S. lives. Tandem also emphasized its entry into the type 2 diabetes market, following FDA clearance of its Control-IQ+ algorithm for type 2 diabetes, which is expected to significantly expand its addressable market. Additionally, the company forecasts a 54% gross margin for 2025, driven by increased Mobi pump sales and efficiency initiatives. Tandem's strategic focus on innovation, including the integration with FreeStyle Libre 3 and the launch of new technology solutions, positions it for long-term growth and profitability.Record-Breaking Revenue and Growth
Tandem Diabetes achieved record annual worldwide sales of $910 million, marking an 18% increase year-over-year. Fourth quarter sales were also a record at $252 million.
Launch of Control-IQ+
The launch of Control-IQ+ is imminent, offering enhancements like superior glucose control and new clinical features, benefiting both type 1 and type 2 diabetes patients.
Type 2 Diabetes Market Expansion
Control-IQ+ received FDA clearance for use in adults with type 2 diabetes, doubling the addressable market in the U.S. and positioning Tandem for significant long-term growth.
International Sales Growth
Sales outside the U.S. grew by 39% year-over-year, driven by strong demand for the t:slim X2 pump, with plans to transition to direct operations in Europe by 2026.
Pharmacy Channel Progress
Tandem has approximately 20% of U.S. lives covered under pharmacy agreements, a strategic move to increase access and affordability for patients.
---
TNDM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TNDM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 26, 2025 | $33.59 | $21.75 | -35.25% |
| Nov 06, 2024 | $34.24 | $33.32 | -2.69% |
| Aug 01, 2024 | $35.21 | $41.67 | +18.35% |
| May 02, 2024 | $36.56 | $44.72 | +22.32% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Tandem Diabetes Care (TNDM) report earnings?
Tandem Diabetes Care (TNDM) is schdueled to report earning on Apr 30, 2025, TBA Not Confirmed.
What is Tandem Diabetes Care (TNDM) earnings time?
Tandem Diabetes Care (TNDM) earnings time is at Apr 30, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TNDM EPS forecast?
TNDM EPS forecast for the fiscal quarter 2025 (Q1) is -0.6.
---
